| __timestamp | Gilead Sciences, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21102000000 | 52602000 |
| Thursday, January 1, 2015 | 28633000000 | 105812000 |
| Friday, January 1, 2016 | 26129000000 | 113485000 |
| Sunday, January 1, 2017 | 21736000000 | 285461000 |
| Monday, January 1, 2018 | 17274000000 | 141726000 |
| Tuesday, January 1, 2019 | 17774000000 | 150446000 |
| Wednesday, January 1, 2020 | 20117000000 | 224227000 |
| Friday, January 1, 2021 | 20704000000 | 361897000 |
| Saturday, January 1, 2022 | 21624000000 | 520812000 |
| Sunday, January 1, 2023 | 20618000000 | 636892000 |
| Monday, January 1, 2024 | 78200000 | 855907000 |
Data in motion
In the ever-evolving landscape of biotechnology, Gilead Sciences, Inc. and Halozyme Therapeutics, Inc. present a fascinating study in contrasts. Over the past decade, Gilead has consistently demonstrated robust financial performance, with gross profits peaking in 2015 at nearly 30% above their 2014 levels. Despite a dip in 2018, Gilead's gross profit has remained resilient, averaging around $21 billion annually.
Conversely, Halozyme Therapeutics, while smaller in scale, has shown impressive growth. From a modest gross profit in 2014, Halozyme has increased its profits by over 1,100% by 2023. This remarkable growth trajectory highlights Halozyme's potential in the biotech sector.
As we look to the future, these two companies exemplify the diverse strategies and outcomes within the biotech industry, offering valuable insights for investors and industry watchers alike.
Key Insights on Gross Profit: AstraZeneca PLC vs Gilead Sciences, Inc.
Gross Profit Trends Compared: Amgen Inc. vs Gilead Sciences, Inc.
Gross Profit Trends Compared: Amgen Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or Alkermes plc
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Corcept Therapeutics Incorporated
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Perrigo Company plc Trends
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Evotec SE Trends
Halozyme Therapeutics, Inc. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis